Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl4):iv192–iv237.
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non-Small Cell Lung Cancer: epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019;94(8):1623–1640.
   PubMed Web of Science ®Google Scholar
• Terlizzi M, Colarusso C, Pinto A, et al. Drug resistance in non-small cell lung Cancer (NSCLC): impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness. Pharmacol Ther. 2019;202:(140–148.
   PubMed Web of Science ®Google Scholar
• Leonetti A, Assaraf YG, Veltsista PD, et al. MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions. Drug Resist Updat. 2019;42:(1–11.
   PubMed Web of Science ®Google Scholar
• Meador CB, Hata AN. Acquired resistance to targeted therapies in NSCLC: updates and evolving insights. Pharmacol Ther. 2020;210:107522.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu T, Wang Q, et al. Circular RNAs: crucial regulators in the human body (Review). Oncol Rep. 2018;40(6):3119–3135.
   PubMed Web of Science ®Google Scholar
• Song L, Cui Z, Guo X. Comprehensive analysis of circular RNA expression profiles in cisplatin-resistant non-small cell lung cancer cell lines. Acta Biochim Biophys Sin (Shanghai). 2020;52(9):944–953.
   PubMed Web of Science ®Google Scholar
• Liang ZZ, Guo C, Zou MM, et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20(1):(173.
   Web of Science ®Google Scholar
• Xu N, Chen S, Liu Y, et al. Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells. Cell Physiol Biochem. 2018;48(5):2046–2060.
   PubMedGoogle Scholar
• Liu Y, Li C, Liu H, et al. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis. Pharmacol Res Perspect. 2021;9(4):e00812.
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng H, Xu Z, et al. Circular RNA SOX13 promotes malignant behavior and cisplatin resistance in non-small cell lung cancer through targeting microRNA-3194-3p/microtubule-associated protein RP/EB family member 1. Bioengineered. 2022;13(1):1814–1827.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhang R, Zhang X, et al. RNA-Seq profiling of circular RNAs and potential function of hsa_circ_0002360 in human lung adenocarcinom. Am J Transl Res. 2019;11(1):160–175.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng S, Wang T. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs. Bioengineered. 2021;12(2):12767–12777.
   PubMed Web of Science ®Google Scholar
• Ding L, Li L, Tang Z. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300. Thorac Cancer. 2022. DOI:10.1111/1759-7714.14342
   Web of Science ®Google Scholar
• Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429.
   PubMed Web of Science ®Google Scholar
• Wei L, Jiang J. Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment. Bioengineered. 2021;12(1):2499–2510.
   PubMed Web of Science ®Google Scholar
• Chen H, Li F, Xue Q. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement. Bioengineered. 2022;13(2):2828–2840.
   PubMed Web of Science ®Google Scholar
• Lu X, Li G, Liu S, et al. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. J Ovarian Res. 2021;14(1):90.
   PubMed Web of Science ®Google Scholar
• Liu C, Yang J, Wu H, et al. Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3. Onco Targets Ther. 2019;12:6525–6534.
   PubMed Web of Science ®Google Scholar
• Xu Y, Dong M, Wang J, et al. LINC01436 Inhibited miR-585-3p Expression and Upregulated MAPK1 Expression to Promote Gastric Cancer Progression. Dig Dis Sci. 2021;66(6):1885–1894.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Li D, Zheng H, et al. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma. Thorac Cancer. 2021;12(19):2526–2536.
   PubMed Web of Science ®Google Scholar
• Zhuang MQ, Li J, Han X, et al. G protein regulated inducer of neurite outgrowth 1 is a potential marker for lung cancer prognosis. J Biol Regul Homeost Agents. 2020;34(3):853–864.
   PubMed Web of Science ®Google Scholar
• Ng EK, Tsang WP, Ng SS, et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer. 2009;101(4):699–706.
   PubMed Web of Science ®Google Scholar
• Zhou C, Liu C, Liu W, et al. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway. Theranostics. 2020;10(10):4627–4643.
   PubMed Web of Science ®Google Scholar
• Chen L, Li H, Yao D, et al. The novel circ_0084904/miR-802/MAL2 axis promotes the development of cervical cancer. Reprod Biol. 2022;22(1):100600.
   PubMed Web of Science ®Google Scholar
• Chu D, Li P, Li Y, et al. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. Thorac Cancer. 2021;12(21):2894–2906.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Pearman CM, Wang Y, et al. Targeting miR-423-5p Reverses Exercise Training–Induced HCN4 Channel Remodeling and Sinus Bradycardia. Circ Res. 2017;121(9):1058–1068.
   PubMed Web of Science ®Google Scholar
• Zhu S, Pan W, Song X, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med. 2012;18(7):1077–1086.
   PubMed Web of Science ®Google Scholar
• Korpal M, Ell BJ, Buffa FM, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011;17(9):1101–1108.
   PubMed Web of Science ®Google Scholar
• Michlewski G, Cáceres JF. Post-transcriptional control of miRNA biogenesis. Rna. 2019;25(1):1–16.
   PubMed Web of Science ®Google Scholar
• Chen Z, Fillmore CM, Hammerman PS, et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546.
   PubMed Web of Science ®Google Scholar
• Wei S, Qi L, Wang L. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis. Anticancer Drugs. 2021;32(5):496–507.
   PubMed Web of Science ®Google Scholar
• Qu F, Wang L, Wang C, et al. Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis. Cancer Cell Int. 2021;21(1):273.
   PubMed Web of Science ®Google Scholar
• Chen Z, Jie Y, Qiu Z, et al. Expression profile and bioinformatics analysis of circular RNAs in tongue squamous cell carcinoma. Oral Dis. 2021. DOI:10.1111/odi.13933.
   Web of Science ®Google Scholar
• Ma Y, Pan X, Xu P, et al. Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI. Oncotarget. 2017;8(51):88529–88536.
   PubMedGoogle Scholar
• Wang Y, Tan H, Yu T, et al. Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines. Front Immunol. 2021;12:(755401.
   Web of Science ®Google Scholar
• Zhou W, Li P, Jin P. miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway. Open Med (Wars). 2021;16(1):1683–1695.
   PubMedGoogle Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.
   PubMed Web of Science ®Google Scholar